Alloferon-1 ameliorates acute inflammatory responses in λ-carrageenan-induced paw edema in mice

Sci Rep. 2022 Oct 6;12(1):16689. doi: 10.1038/s41598-022-20648-z.

Abstract

Alloferon-1 have been proposed as an effective peptide to enhance antitumoral immunity, antiviral defense and anti-inflammatory activity. This work aimed to assess anti-inflammatory effects of alloferon-1 against acute inflammation and histopathological deformations in λ-carrageenan-induced paw edema in mice. Systemic pretreatment with alloferon-1 (22.0 mg/kg) intraperitoneally injected mice showed a significant reduction in paw thickness and vascular permeability. Alloferon-1 prevented λ-carrageenan-evoked exudation and the neutrophil influx to the mouse pleura and the neutrophil migration into carrageenan-stimulated mouse air pouches based on the histopathological changes in the paw tissues. Administration of alloferon-1 also suppressed the expression of the inflammatory cytokines in the inflamed paw tissues such as tumor necrosis factor-α (TNF-α), monocyte chemoattractant protein 1 (MCP1), interleukin-5 (IL-5), etc. detected by Luminex liquid chip. Collectively, the present study provides evidences for the marked anti-inflammatory effects of alloferon-1 which might represent new therapeutic options for the treatment of acute inflammatory diseases.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Anti-Inflammatory Agents
  • Antiviral Agents / therapeutic use
  • Carrageenan / toxicity
  • Chemokine CCL2
  • Cytokines / therapeutic use
  • Edema / chemically induced
  • Edema / drug therapy
  • Edema / metabolism
  • Inflammation / drug therapy
  • Interleukin-5*
  • Mice
  • Peptides
  • Tumor Necrosis Factor-alpha* / metabolism

Substances

  • Alloferon
  • Anti-Inflammatory Agents
  • Antiviral Agents
  • Chemokine CCL2
  • Cytokines
  • Interleukin-5
  • Peptides
  • Tumor Necrosis Factor-alpha
  • Carrageenan